Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vinflunine + capecitabine vs capecitabine in advanced breast cancer
CTR20131445Phase 3Active
- Sponsor
- Pierre Fabre Laboratories
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of vinflunine in breast cancer, sponsored by Pierre Fabre Laboratories. Started Nov 2013; status: active.
02
Drugs
vinflunine
03
Conditions
breast cancer
Beyond the preview
Go deeper on CTR20131445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131445.